Correlation Between Dyne Therapeutics and Vaxcyte

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dyne Therapeutics and Vaxcyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dyne Therapeutics and Vaxcyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dyne Therapeutics and Vaxcyte, you can compare the effects of market volatilities on Dyne Therapeutics and Vaxcyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dyne Therapeutics with a short position of Vaxcyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dyne Therapeutics and Vaxcyte.

Diversification Opportunities for Dyne Therapeutics and Vaxcyte

DyneVaxcyteDiversified AwayDyneVaxcyteDiversified Away100%
0.5
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Dyne and Vaxcyte is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Dyne Therapeutics and Vaxcyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vaxcyte and Dyne Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dyne Therapeutics are associated (or correlated) with Vaxcyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vaxcyte has no effect on the direction of Dyne Therapeutics i.e., Dyne Therapeutics and Vaxcyte go up and down completely randomly.

Pair Corralation between Dyne Therapeutics and Vaxcyte

Considering the 90-day investment horizon Dyne Therapeutics is expected to generate 1.13 times less return on investment than Vaxcyte. In addition to that, Dyne Therapeutics is 1.66 times more volatile than Vaxcyte. It trades about 0.03 of its total potential returns per unit of risk. Vaxcyte is currently generating about 0.05 per unit of volatility. If you would invest  3,788  in Vaxcyte on December 12, 2024 and sell it today you would earn a total of  3,197  from holding Vaxcyte or generate 84.4% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Dyne Therapeutics  vs.  Vaxcyte

 Performance 
JavaScript chart by amCharts 3.21.15Dec2025Feb -50-40-30-20-100
JavaScript chart by amCharts 3.21.15DYN PCVX
       Timeline  
Dyne Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Dyne Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
JavaScript chart by amCharts 3.21.15JanFebMarFebMar152025
Vaxcyte 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Vaxcyte has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
JavaScript chart by amCharts 3.21.15JanFebMarFebMar7075808590

Dyne Therapeutics and Vaxcyte Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-9.41-7.05-4.68-2.32-0.03941.833.695.557.42 0.0150.0200.0250.0300.0350.040
JavaScript chart by amCharts 3.21.15DYN PCVX
       Returns  

Pair Trading with Dyne Therapeutics and Vaxcyte

The main advantage of trading using opposite Dyne Therapeutics and Vaxcyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dyne Therapeutics position performs unexpectedly, Vaxcyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaxcyte will offset losses from the drop in Vaxcyte's long position.
The idea behind Dyne Therapeutics and Vaxcyte pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Stocks Directory
Find actively traded stocks across global markets
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years